Structure via PubChem · Public domain (PubChem)
glyclopyramide
Sign in to saveGlyclopyramide (INN, marketed under the tradename Deamelin-S) is a sulfonylurea drug used in the treatment of diabetes. It has been marketed in Japan since 1965.
In the Vinony graph
Vinony's link graph records 445 inbound references to glyclopyramide, and connects out to metformin, valproic acid and alogliptin.
Vinony files it under 1-Pyrrolidinyl compounds, 4-Chlorophenyl compounds and Benzenesulfonylureas.
Vinony links it to 7 Wikipedia language editions.
Chemical data
- Formula
- C11H14ClN3O3S
- Molecular weight
- 303.77 g/mol
- IUPAC name
- 1-(4-chlorophenyl)sulfonyl-3-pyrrolidin-1-ylurea
- SMILES
- C1CCN(C1)NC(=O)NS(=O)(=O)C2=CC=C(C=C2)Cl
- InChIKey
- HNSCCNJWTJUGNQ-UHFFFAOYSA-N
- XLogP
- 0.9
- Polar surface area
- 86.9 Ų
- H-bond donors
- 2
- H-bond acceptors
- 4
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Phase 2
- Molecule type
- Small molecule
via ChEMBL · EBI
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 303.044
Show 2 more facts
- chemical formula
- C₁₁H₁₄ClN₃O₃S
- canonical SMILES
- C1CCN(C1)NC(=O)NS(=O)(=O)C2=CC=C(C=C2)Cl
Sources (2)
via Wikidata · CC0
~1 min read
Encyclopedic overview
2 sectionsContents
- References
- External links
Glyclopyramide (INN, marketed under the tradename Deamelin-S) is a sulfonylurea drug used in the treatment of diabetes. It has been marketed in Japan since 1965.
It is classified as second generation.
Excerpted from Wikipedia’s “glyclopyramide” article, available under the CC BY-SA 4.0 licence.